Abstract：Melanoma associated antigen family A1 (MAGEA1) is expressed in germ cells and tumors of various histological origins, but its mechanism is still unclear. In this study, the eukaryotic recombinant MAGEA1 expression plasmids with Flag or GFP tags were constructed and transfected into HeLa and HEK293T cells. Western blotting, immunocytochemistry, co-immunoprecipitation, nuclear protein and cytoplasmic protein separation, and mitochondrial isolation were used to detect the expression and location of MAGEA1 and its interaction with other proteins in cells. The results of immunocytochemistry (ICC) and Western blotting showed that the overexpressed MAGEA1 was mainly localized in the cytoplasm and partially co-localized with mitochondria. Co-immunoprecipitation experiments verified the interactions between MAGEA1 and TRIM31, SNW1, HDAC1, and found that MAGEA1 may mainly interact with HDAC1 in the cytoplasm. The studies above indicate that MAGEA1 may be involved in different cellular biological processes and co-localize with mitochondria. It interacts with TRIM31, SNW1 and HDAC1, while MAGEA1 may mainly interact with HDAC1 in the cytoplasm. We propose that it may be involved in protein ubiquitination and the Notch signaling pathway. The results of this study laid an experimental foundation for the subsequent in-depth study of the mechanism of MAGEA1.
李瑜颖, 钟子琳, 陈建军. 黑色素瘤相关抗原MAGEA1的定位及其相互作用蛋白质的鉴定[J]. 中国生物化学与分子生物学报, 2021, 37(6): 765-771.
LI Yu-Ying, ZHONG Zi-Lin, CHEN Jian-Jun. Localization of Melanoma-associated Antigen MAGEA1 and Identification of Its Interacting Proteins. Chinese Journal of Biochemistry and Molecular Biol, 2021, 37(6): 765-771.
[1] Lee AK, Potts PR. A comprehensive guide to the MAGE family of ubiquitin ligases[J]. J Mol Biol,2017, 429 (8):1114-1142 [2] Wischnewski F, Friese O, Pantel K, et al. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and IMAGE-A12 gene promoters[J]. Mol Cancer Res, 2007,5(7):749-759 [3] Loriot A, Sterpin C, De Backer O, et al. Mouse embryonic stem cells induce targeted DNA demethylation within human MAGE-A1 transgenes[J]. Epigenetics, 2008,3(1):38-42 [4] Schooten E, Di Maggio A, Henegouwen PMPVE, et al. MAGE-A antigens as targets for cancer immunotherapy[J]. Cancer Treat Rev, 2018,67:54-62 [5] Zhao J, Wang Y, Liang Q, et al. MAGEA1 inhibits the expression of BORIS via increased promoter methylation[J]. J Cell Sci, 2019,132(1):jcs218628 [6] Schwarzenbach H, Eichelser C, Steinbach B, et al. Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein[J]. BMC Cancer, 2014, 14:796 [7] van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma[J]. J Immunol, 2007,178(5):2617-2621 [8] Grau E, Oltra S, Martinez F, et al. MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors[J]. J Cancer Res Clin Oncol, 2009,135(4):523-531 [9] Mao Y, Fan WF, Hu H, et al. MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells[J]. J Hematol Oncol, 2019,12(1):106 [10] Chen PW, Murray TG, Uno T, et al. Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease[J]. Clin Exp Metastas, 1997,15(5):509-518 [11] Hansel DE, House MG, Ashfaq R, et al. MAGE1 is expressed by a subset of pancreatic endocrine neoplasms and associated lymph node and liver metastases[J]. Int J Gastrointest Cancer, 2003,33(2-3):141-147 [12] Qiu G, Fang JC, He YS. 5′ CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC[J]. Clin Biochem, 2006,39(3):259-266 [13] Newman JA, Cooper CDO, Roos AK, et al. Structures of two melanoma-associated antigens suggest allosteric regulation of effector binding[J]. PLoS One, 2016, 11(2):e0148762 [14] Hagiwara Y, Sieverling L, Hanif F, et al. Consequences of point mutations in melanoma-associated antigen 4 (MAGE-A4) protein: Insights from structural and biophysical studies [J]. Sci Rep, 2016, 6:25182 [15] Zhao J, Wang Y, Mu C, et al. MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells [J]. Oncogene, 2017,36(35):5023-5034 [16] Kozakova L, Vondrova L, Stejskal K, et al. The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complex[J]. Cell Cycle, 2015, 14(6):920-930 [17] Laduron S, Deplus R, Zhou S, et al. MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription[J]. Nucleic Acids Res, 2004,32(14):4340-4350 [18] Sugiura T, Miyamoto K. Characterization of TRIM31, upregulated in gastric adenocarcinoma, as a novel RBCC protein[J]. J Cell Biochem, 2008,105(4):1081-1091 [19] Lefevere E, Toft-Kehler AK, Vohra R, et al. Mitochondrial dysfunction underlying outer retinal diseases[J]. Mitochondrion, 2017,36:66-76 [20] Woodhoo A, Alonso MBD, Droggiti A, et al. Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity[J]. Nat Neurosci, 2009,12(7):839-U847 [21] Kruczek K, Gonzalez-Cordero A, Goh D, et al. Differentiation and transplantation of embryonic stem cell-derived cone photoreceptors into a mouse model of end-stage retinal degeneration [J]. Stem Cell Reports, 2017,8(6):1659-1674 [22] Zhu Y, Vidaurre OG, Adula KP, et al. Subcellular distribution of HDAC1 in neurotoxic conditions is dependent on serine phosphorylation[J]. J Neurosci, 2017,37(31):7547-7559 [23] Kim JY, Shen S, Dietz K, et al. HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage[J]. Nat Neurosci, 2010,13(2):180-189
